FDA Investigator

Reyes Candau-Chacon

Latest inspection on record: Visp, Switzerland, October 2025 · records back to 2012

Human DrugsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 40 inspections across 35 sites are on record.
  • 3 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-10-28.

At a glance

Inspections

40

Sites

35

Observations

3

Career since

Jan 2012

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Lonza AG28 Oct 2025Human DrugsOn file
Incyte Biosciences Technical Operations Sarl11 Feb 2025Human DrugsOn file
F. Hoffmann-La Roche AG4 Nov 2024Human DrugsOn file
F. Hoffmann-La Roche AG4 Nov 2024Human DrugsOn file
AGC Biologics A/S5 Nov 2019Human DrugsOn file

Sites inspected

Lonza AGVisp, Switzerland1 insp.
Incyte Biosciences Technical Operations SarlYverdon-Les-Bains, Switzerland1 insp.
F. Hoffmann-La Roche AGBasel Town, Switzerland1 insp.
F. Hoffmann-La Roche AGKaiseraugst, Switzerland1 insp.
AGC Biologics A/SSoborg, Denmark1 insp.

Co-investigators

Investigators who share inspections with this person.

Bo Chi4 shared
Steven Fong2 shared
Alexander R Sohr1 shared
Lei Zhang1 shared

Full investigator report

Get the verbatim findings behind Reyes Candau-Chacon's 3 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site